Jpmorgan Chase & CO Soleno Therapeutics Inc Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.14 - $0.23 $210 - $346	-1,507 Reduced 94.13%	94 $0
Q1 2022 May 11, 2022	BUY	$0.22 - $0.47 $331 - $708	1,507 Added 1603.19%	1,601 $0
Q4 2021 Feb 10, 2022	SELL	$0.41 - $0.91 $0 - $0	-1 Reduced 1.05%	94 $0
Q3 2021 Nov 12, 2021	BUY	$0.8 - $1.12 $76 - $106	95 New	95 $0

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.